Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2021

Nov 9, 2021

29841_dirs_2021-11-09_5c48f19e-1a06-4cff-97bc-a992c53bee7f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2021-11-05

Reporting Person: Kuntz Richard (SVP & Chief Medical & Science)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-05 Ordinary Shares F 209 $122.98 Disposed 74945 Direct

Footnotes

F1: This balance increased by 239 shares due to exempt transactions such as dividend reinvestment.

F2: The reported transaction involved the withholding of 209 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.